Cargando…

Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database

OBJECTIVES: Adverse reactions to the COVID-19 vaccines have been of interest since their emergency authorization. Cutaneous manifestations of the vaccines are not well studied. We aimed to characterize cutaneous reactions to the Moderna (mRNA-1273) and the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falotico, Julianne M., Desai, Amar D., Shah, Asghar, Ricardo, Jose W., Lipner, Shari R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361907/ https://www.ncbi.nlm.nih.gov/pubmed/35931925 http://dx.doi.org/10.1007/s40257-022-00715-x

Ejemplares similares

Updated Perspectives on the Diagnosis and Management of Onychomycosis
por: Falotico, Julianne M, et al.
Publicado: (2022)

Importance of Board-Certified Dermatologist Online Reviews: Small Steps to Improve Patient Experiences and Perspectives
por: Falotico, Julianne M., et al.
Publicado: (2023)

Nail Dermatologist and Patient Educational Content Lacks Adequate Skin of Color Representation: Implications for Care
por: Falotico, Julianne M., et al.
Publicado: (2023)

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)

Vocal Fold Paralysis Following COVID-19 Vaccination: Query of VAERS Database
por: Hamdi, Osama A., et al.
Publicado: (2022)

Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports
por: Riad, Abanoub, et al.
Publicado: (2022)

Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials
por: Falotico, Julianne M., et al.
Publicado: (2022)

Ontology-based time information representation of vaccine adverse events in VAERS for temporal analysis
por: Tao, Cui, et al.
Publicado: (2012)

Identification of sex-associated network patterns in Vaccine-Adverse Event Association Network in VAERS
por: Zhang, Yuji, et al.
Publicado: (2015)

COVID-19 vaccine adverse events in a population aged 5–17 years: a study from the VAERS database
por: Villa-Zapata, Lorenzo, et al.
Publicado: (2023)

COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Zhang, Bing, et al.
Publicado: (2022)

Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
por: Lipner, Shari R., et al.
Publicado: (2020)

Vaccines and sudden infant death: An analysis of the VAERS database 1990–2019 and review of the medical literature
por: Miller, Neil Z.
Publicado: (2021)

Glaucoma Cases Following SARS-CoV-2 Vaccination: A VAERS Database Analysis
por: Singh, Rohan Bir, et al.
Publicado: (2022)

Reports of Guillain–Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database
por: Chalela, Julio A., et al.
Publicado: (2023)

Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database
por: Santi Laurini, Greta, et al.
Publicado: (2023)

Linked vaccine adverse event data from VAERS for biomedical data analysis and longitudinal studies
por: Tao, Cui, et al.
Publicado: (2014)

Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports
por: Guo, Wenxin, et al.
Publicado: (2022)

Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics’ impact
por: Almadani, Ohoud A., et al.
Publicado: (2022)

Novel solutions for dermatologic care of geriatric patients and the role of the dermatology house call
por: Lipner, Shari R., et al.
Publicado: (2020)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

Analysis of skin color in the American Academy of Dermatology basic dermatology curriculum
por: Chang, Michelle J., et al.
Publicado: (2021)

Adverse event detection by integrating twitter data and VAERS
por: Wang, Junxiang, et al.
Publicado: (2018)

Trivalent influenza vaccine adverse symptoms analysis based on MedDRA terminology using VAERS data in 2011
por: Du, Jingcheng, et al.
Publicado: (2016)

Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis
por: Santi Laurini, Greta, et al.
Publicado: (2023)

Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review
por: Tay, Woo Chiao, et al.
Publicado: (2023)

EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5–17 Years: A Study of Reports from the VAERS Database
por: Lee, Y, et al.
Publicado: (2022)

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)

Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data
por: Tao, Cui, et al.
Publicado: (2015)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
por: Niebel, Dennis, et al.
Publicado: (2021)

Racial discrepancies in presentation of hospitalized infantile hemangioma cases using the Kids' Inpatient Database
por: Kumar, Keshav D., et al.
Publicado: (2023)

Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program
por: Albucker, Samantha Jo, et al.
Publicado: (2023)

Relative trends in hospitalizations and mortality among infants by the number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990–2010
por: Goldman, GS, et al.
Publicado: (2012)

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015
por: Moro, Pedro L., et al.
Publicado: (2016)

EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS)
por: Alahmari, AK, et al.
Publicado: (2022)

Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”
por: Cohen, Carine, et al.
Publicado: (2018)

Venture capital funding of dermatology companies founded by women: a unique set of challenges
por: Desai, Amar D., et al.
Publicado: (2023)

Dermatologic manifestations of hydroxychloroquine therapy: A closer look at the nails
por: Lipner, Shari R., et al.
Publicado: (2020)

Cardiovascular Complications are Common in Patients with Juvenile Dermatomyositis in a Cross-Sectional Analysis of the 2016 Kids Inpatient Database
por: Desai, Amar D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bcf2drm1niqqs086o15hf9liqi